Showing 2974 results
-
Featured News /
Jay Bradner, President of the Novartis Institutes for BioMedical Research (NIBR) and Vas Narasimhan, Head of Global Drug Development and Chief Medical Officer, share their outlook for innovation in 2017.
-
Story /Read how two sites within the Novartis Technical Operations (NTO) network ensured business continuity at scale and speed in the midst of the COVID-19 pandemic.
-
Story /Meet Melanoma survivor TJ Sharpe in the first installment of his new blog series on Novartis.com.
-
Story /Discover how COPD assessment and treatment are changing.
-
In The News /Novartis CEO Vas Narasimhan discusses how to improve pandemic preparedness at the CNBC Evolve Global Summit.
-
Story /The recently appointed leader of the Novartis’ digital research and development platform data42 is a strong believer that data and digital technologies will change the path of medical science.
-
Featured News /
Cell Therapies Pty Ltd has become the first approved CAR-T commercial manufacturing site in Australia, providing potentially faster access to CAR-T therapies to eligible patients in the region with life-threatening blood cancers.
Novartis global commercial CAR-T manufacturing footprint now spans four continents, bringing these transformative therapies closer to patients and healthcare professionals around the world. -
Story /Meet our Vice President of Strategic Data and Digital at Novartis Oncology.
-
Story /New Global Head of Business Development and Licensing for research makes connections naturally, decisions scientifically.
-
Statement /